Page last updated: 2024-11-05

piminodine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

piminodine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21950
CHEMBL ID2110995
CHEBI ID135546
SCHEMBL ID26477
MeSH IDM0445074

Synonyms (42)

Synonym
4-piperidinecarboxylic acid, 4-phenyl-1-[3-(phenylamino)propyl]-, ethyl ester
piminodine
piminodine [inn:ban]
win 14098-2
anopridine
alvodine
einecs 236-817-6
nih 7590
piminodina [inn-spanish]
piminodinum [inn-latin]
4-phenyl-1-(3-(phenylamino)propyl)-4-piperidinecarboxylic acid ethyl ester
pimadin
pimadin (analgesic)
4-piperidinecarboxylic acid, 4-phenyl-1-(3-(phenylamino)propyl)-, ethyl ester
cimadon
pimadine
win 14098
dea no. 9730
brn 0334632
CHEBI:135546
ethyl 1-(3-anilinopropyl)-4-phenylpiperidine-4-carboxylate
piminodina
3iix447hws ,
13495-09-5
5-22-02-00490 (beilstein handbook reference)
isonipecotic acid, 1-(3-anilinopropyl)-4-phenyl-, ethyl ester
unii-3iix447hws
piminodinum
piminodine [mi]
piminodine [inn]
ids-np-012
piminodine [who-dd]
SCHEMBL26477
piminodin
CHEMBL2110995
PXXKIYPSXYFATG-UHFFFAOYSA-N
ethyl 1-(3-anilinopropyl)-4-phenyl-4-piperidinecarboxylate #
DTXSID60159149
piminodine alvodine,pimadin,cimapon
HY-U00297
CS-7266
Q7194651
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
piperidines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.52 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]